We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Next-Generation Sequencing for SARS-CoV-2 Surveillance
Industry Insight

To gain some insights into the role of NGS in global SARS-CoV-2 surveillance, we spoke to Michelle Fraser, general manager, NGS for PerkinElmer. Michelle also explains how labs working in this area can increase their throughput, decrease associated costs and simplify the analysis of NGS data collected.

Read More

Minipig Study Tests Gene Therapy for Huntington's Disease
Industry Insight

A new body of work published in Science Translational Medicine outlines the preclinical testing of a microRNA-based gene therapy for Huntington's disease – AMT-130 – in minipigs.

Read More

Bioprocessing and Bioproduction Trends in Cell and Gene Therapies
Industry Insight

In this interview, Technology Networks spoke with Neal Goodwin, PhD, Chief Scientific Officer at Teknova, to learn more about current bioprocessing and bioproduction trends in the cell and gene therapy space. Goodwin also discusses the impact of the COVID-19 pandemic on the biopharmaceutical sector and highlights how the industry has united to contribute to the development of vaccines at this critical time.

Read More

Using Rapid Antigen Tests To Fight SARS-CoV-2
Industry Insight

Technology Networks recently interviewed Anthony V. Lemmo, to learn how rapid antigen tests work, how they compare to PCR tests and how they can be used to help slow the spread of SARS-CoV-2.

Read More

Tackling the Spread of SARS-CoV-2 Variants
Industry Insight

Public health groups and leaders around the world are adopting different approaches for viral tracking and monitoring to halt the spread of novel SARS-CoV-2 variants.

Read More

Engineering the Future of Genetic Medicine
Industry Insight

Technology Networks recently interviewed Benjamin Oakes, co-founder, president and CEO at Scribe, to learn more about the company's next steps in "fulfilling the promise of CRISPR" and how it will navigate some of the challenges associated with developing CRISPR-based therapeutics, including efficacy, scale-up and high costs.

Read More

Supporting Scientists Responding to the COVID-19 Pandemic
Industry Insight

The development and implementation of efficient tests is crucial in efforts to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Read More

An Automated Age for Western Blotting
Industry Insight

Western blotting has been a core technique in molecular biology for many years, however, optimization and reproducibility can be problematic. We spoke to Dr Alexandre Lucas about the automation of western blotting and the difference this advance is making to research.

Read More

Accelerating Scientific Study With Scalable Single-Cell Sequencing
Industry Insight

Technology Networks recently interviewed Alex Rosenberg, co-founder and CEO of Parse Biosciences to learn more about the company and its novel approach to single-cell sequencing.

Read More

Detecting Mutations With Liquid Biopsies
Industry Insight

Here we summarize the webinar that was hosted by Monika Seidel Ph.D., in which she discussed detecting mutations with liquid biopsies in cancer diagnostics.

Read More

 
Advertisement